Market closed
Canopy Growth/$CGC
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Canopy Growth
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Ticker
$CGC
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Smiths Falls, Canada
Employees
1,029
Website
Canopy Growth Metrics
BasicAdvanced
$167M
-
-$3.60
1.73
-
Price and volume
Market cap
$167M
Beta
1.73
52-week high
$14.92
52-week low
$0.88
Average daily volume
7.5M
Financial strength
Current ratio
3.516
Quick ratio
2.344
Long term debt to equity
79.112
Total debt to equity
82.789
Interest coverage (TTM)
-1.16%
Management effectiveness
Return on assets (TTM)
-4.63%
Return on equity (TTM)
-84.02%
Valuation
Price to revenue (TTM)
0.494
Price to book
0.33
Price to tangible book (TTM)
0.42
Price to free cash flow (TTM)
-0.84
Growth
Revenue change (TTM)
-5.41%
Earnings per share change (TTM)
-72.38%
3-year revenue growth (CAGR)
-20.80%
3-year earnings per share growth (CAGR)
-27.48%
What the Analysts think about Canopy Growth
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Canopy Growth stock.
Canopy Growth Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Canopy Growth Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Canopy Growth News
AllArticlesVideos
Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand
Business Wire·1 day ago
Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million
Business Wire·2 days ago
March 2025 Watchlist: Best Canadian Marijuana Stocks to Track Now
MarijuanaStocks·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Canopy Growth stock?
Canopy Growth (CGC) has a market cap of $167M as of April 03, 2025.
What is the P/E ratio for Canopy Growth stock?
The price to earnings (P/E) ratio for Canopy Growth (CGC) stock is 0 as of April 03, 2025.
Does Canopy Growth stock pay dividends?
No, Canopy Growth (CGC) stock does not pay dividends to its shareholders as of April 03, 2025.
When is the next Canopy Growth dividend payment date?
Canopy Growth (CGC) stock does not pay dividends to its shareholders.
What is the beta indicator for Canopy Growth?
Canopy Growth (CGC) has a beta rating of 1.73. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.